Literature DB >> 12853096

Hepatocellular carcinoma: surgical indications and results.

Guillermo Marín-Hargreaves1, Daniel Azoulay, Henri Bismuth.   

Abstract

Hepatocellular carcinoma (HCC) is a tumour of increasing incidence that usually arises in cirrhotic liver. Untreated, the prognosis is grim and the only curative treatment is surgical resection. The practical application of segmental surgery to the liver together with the use of ultrasound and other imaging techniques, patient selection criteria and improvements in perioperative technique and postoperative care have contributed to better results in hepatic surgery. Today, less than 10% mortality for resection of cirrhotic livers, with up to 50% 5-year survival rates are to be expected. However, the limits of resection for cure: intrahepatic recurrence makes stringent follow-up necessary. In this way the available modalities of treatment can be applied so as to improve survival. Herein, a current 'state-of-the-art' of surgical indications and results for HCC is given.

Entities:  

Mesh:

Year:  2003        PMID: 12853096     DOI: 10.1016/s1040-8428(02)00213-5

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  32 in total

Review 1.  Management of solitary 1 cm to 2 cm liver nodules in patients with compensated cirrhosis: a decision analysis.

Authors:  Karen E Bremner; Ahmed M Bayoumi; Morris Sherman; Murray D Krahn
Journal:  Can J Gastroenterol       Date:  2007-08       Impact factor: 3.522

Review 2.  Effect of liver regeneration on malignant hepatic tumors.

Authors:  Ji-Hua Shi; Pål-Dag Line
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

3.  Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma conforming to the Milan criteria: systemic review and meta-analysis.

Authors:  Hui-Ming Yi; Wei Zhang; Xi Ai; Kai-Yan Li; You-Bin Deng
Journal:  Int J Clin Exp Med       Date:  2014-10-15

4.  Three-dimensional evaluation of lipiodol retention in HCC after chemoembolization: a quantitative comparison between CBCT and MDCT.

Authors:  Zhijun Wang; Mingde Lin; David Lesage; Rongxin Chen; Julius Chapiro; Tara Gu; Vania Tacher; Rafael Duran; Jean-François Geschwind
Journal:  Acad Radiol       Date:  2014-03       Impact factor: 3.173

Review 5.  Hepatectomy for hepatocellular carcinoma in the era of liver transplantation.

Authors:  Wen-Ping Lu; Jia-Hong Dong
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

6.  Superior long-term outcomes after surgery in child-pugh class a patients with single small hepatocellular carcinoma compared to radiofrequency ablation.

Authors:  Won Kyoung Yun; Moon Seok Choi; Dongil Choi; Hyun-Chul Rhim; Jae Won Joh; Kyung Hee Kim; Tae Hoon Jang; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo
Journal:  Hepatol Int       Date:  2010-12-25       Impact factor: 6.047

7.  Current management of hepatocellular cancer.

Authors:  Bernardino Rampone; Beniamino Schiavone; Giuseppe Confuorto
Journal:  Curr Oncol Rep       Date:  2010-05       Impact factor: 5.075

8.  Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE).

Authors:  R Iezzi; V Cesario; L Siciliani; M Campanale; A M De Gaetano; M Siciliano; S Agnes; F Giuliante; A Grieco; M Pompili; G L Rapaccini; A Gasbarrini; L Bonomo
Journal:  Radiol Med       Date:  2013-01-28       Impact factor: 3.469

9.  Transcatheter arterial chemoembolization followed by immediate radiofrequency ablation for large solitary hepatocellular carcinomas.

Authors:  Zhi-Jun Wang; Mao-Qiang Wang; Feng Duan; Peng Song; Feng-Yong Liu; Zhong-Fei Chang; Yan Wang; Jie-Yu Yan; Kai Li
Journal:  World J Gastroenterol       Date:  2013-07-14       Impact factor: 5.742

10.  The association between central venous pressure, pneumoperitoneum, and venous carbon dioxide embolism in laparoscopic hepatectomy.

Authors:  S Jayaraman; A Khakhar; H Yang; D Bainbridge; D Quan
Journal:  Surg Endosc       Date:  2009-03-06       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.